In Pain? 98-Rated Stock Offers Innovative Relief (and Profits!)
Millions of Americans don’t want pills to manage pain. That’s great news for this medical devices company.
Posted by Matthew Clark | Jan 2, 2023 | Money & Markets Daily
Millions of Americans don’t want pills to manage pain. That’s great news for this medical devices company.
Posted by Matthew Clark | Dec 30, 2022 | Money & Markets Daily
With inflation still front of mind, investors are scrambling to find a hedge. Precious metals stocks like this one will benefit.
Posted by Matthew Clark | Dec 29, 2022 | Investing
Russia’s invasion sent Brent and West Texas Intermediate crude oil prices to 2014 highs. Here’s how it can hit $500 a barrel from here.
Posted by Matthew Clark | Dec 28, 2022 | Money & Markets Daily
Equitrans stock (NYSE: ETRN) is one to avoid, even as the oil and gas sector rips higher. Here’s why this stock has a tough road ahead.
Posted by Matthew Clark | Dec 27, 2022 | Money & Markets Daily
This tiny company is set to profit as the U.S. produces 33.7 trillion cubic feet of shale gas and tight oil by 2050.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below